CS logo
small CS logo
Kantonsspital Baselland - Standort Liestal

Liestal, Switzerland
Staatliches Krankenhaus in Liestal

About Kantonsspital Baselland - Standort Liestal


Das Kantonsspital Baselland ist eine Anstalt des öffentlichen Rechts des Kantons Basel-Landschaft und entstand im März 2012 durch Zusammenlegung des Kantonsspitals Liestal, des Kantonsspitals Laufen und des Bruderholzspitals in Binningen.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Kantonsspital Baselland - Standort Liestal


During the past decade, Kantonsspital Baselland - Standort Liestal conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Baselland - Standort Liestal" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Swiss National Science Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Kantonsspital Baselland - Standort Liestal


According to Clinical.Site data, the most researched conditions in "Kantonsspital Baselland - Standort Liestal" are "Triple Negative Breast Cancer" (2 trials), "Angina, Unstable" (1 trials), "Myocardial Infarction" (1 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Kantonsspital Baselland - Standort Liestal" in a lesser frequency.

Clinical Trials Intervention Types at Kantonsspital Baselland - Standort Liestal


Most popular intervention types in "Kantonsspital Baselland - Standort Liestal" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Kantonsspital Baselland - Standort Liestal


The vast majority of trials in "Kantonsspital Baselland - Standort Liestal" are 3 trials for "All" genders.

Clinical Trials Status at Kantonsspital Baselland - Standort Liestal


Currently, there are NaN active trials in "Kantonsspital Baselland - Standort Liestal". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kantonsspital Baselland - Standort Liestal, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kantonsspital Baselland - Standort Liestal, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".